Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results

Stock Information for 180 Degree Capital Corp.

Loading

Please wait while we load your information from QuoteMedia.